Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: Andy Walker

Juno Therapeutics – next generation CAR technology

Posted on by

Juno Therapeutics is a biopharma company developing novel cellular immunotherapies based on two distinct and complementary platforms: T Cell Receptors (TCRs) and Chimeric Antigen Receptors (CARs) technologies.

Juno Therapeutics – next generation CAR technology

Juno Therapeutics Continue reading →

Posted in Biotech Companies, Biotech Companies USA | Tagged Andy Walker, Anthony Evnin, B-cell leukemia, B-cell leukemias, B-cell lymphoma, B-cell lymphomas, Barney Cassidy, CAR, CARs, cell-based cancer immunotherapies, cellular immunotherapies, Chimeric Antigen Receptor, Chimeric Antigen Receptors, Elizabeth Smith, Hal Barron, Hans Bishop, Howard Pien, Isabelle Rivière, Jeff Bluestone, José Baselga, Juno Therapeutics, Juno Therapeutics - next generation CAR technology, Ken Mohler, Larry Corey, Marc Tessier-Lavigne, Mark Frohlich, Mark Gilbert, Mary Agnes Wilderotter, Michael Jensen, Michel Sadelain, next generation CAR technology, Phil Greenberg, Renier Brentjens, Richard Klausner, Robert Nelsen, Robin Andrulevich, Stan Riddell, Steve Harr, TCR, TCRs

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress